The Enterprise Value as of November 2025 (TTM) for Alseres Pharmaceuticals, Inc. (ALSE) is 8.10M

According to Alseres Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.10M. This represents a change of -8.83% compared to the average of 8.89M of the last 4 quarters.

Alseres Pharmaceuticals, Inc. (ALSE) Historical Enterprise Value (quarterly & annually)

How has ALSE Enterprise Value performed in the past?

The mean historical Enterprise Value of Alseres Pharmaceuticals, Inc. over the last ten years is 35.57M. The current 8.10M Enterprise Value has changed 2.18% with respect to the historical average. Over the past ten years (40 quarters), ALSE's Enterprise Value was at its highest in in the December 2007 quarter at 82.64M. The Enterprise Value was at its lowest in in the December 2012 quarter at 6.88M.

Alseres Pharmaceuticals, Inc. (ALSE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Alseres Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alseres Pharmaceuticals, Inc. (ALSE) Average Enterprise Value

How has ALSE Enterprise Value performed in the past?

The current Enterprise Value of Alseres Pharmaceuticals, Inc. (ALSE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Alseres Pharmaceuticals, Inc. (ALSE) Enterprise Value vs. Peers

How is ALSE’s Enterprise Value compared to its peers?

Alseres Pharmaceuticals, Inc.’s Enterprise Value is greater than Achiko AG (2.87M), greater than Lotus Ventures Inc. (3.29M), greater than Evolva Holding S.A. (-673566.00), greater than FluroTech Ltd. (356.30K), less than Digicann Ventures Inc. (18.82M), less than TuHURA Biosciences, Inc. (92.82M), greater than Phoenix Life Sciences International Limited (200.09K), greater than Aquarius Surgical Technologies Inc. (6.84M), less than Kiromic BioPharma, Inc. (13.65M), less than Hemogenyx Pharmaceuticals Plc (31.11M),

Build a custom stock screener for Alseres Pharmaceuticals, Inc. (ALSE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alseres Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alseres Pharmaceuticals, Inc. (ALSE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alseres Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.